SEP 24, 2021 1:16 PM PDT

Nasal Drugs Show Promise for Slowing Parkinson's Disease

WRITTEN BY: Annie Lennon

Two drugs delivered via the nose have shown promise for improving symptoms of Parkinson's disease in mice. The corresponding study was published in Nature Communications by researchers at Rush University Medical Center in Chicago, IL. 

Parkinson's disease affects around 6.1 million people worldwide and is the most common movement disorder. One of the characteristic markers of the disease is the presence of Lewy bodies, abnormal protein deposits involving alpha-synuclein proteins that develop in nerve cells in various regions of the brain. 

Until now, the underlying mechanisms controlling the spread of alpha-synuclein and its link to Parkinson's disease have been unknown. Nevertheless, the buildup of these proteins is also associated with Lewy body dementia and a rare neurological disorder known as multiple system atrophy (MSA). 

"At present, there is also no effective treatment for dementia with Lewy bodies and multiple system atrophy," said Kalipada Pahan, lead author of the study. "Understanding how these diseases work is important to developing effective drugs that inhibit alpha-synuclein pathology, protect the brain, and stop the progression of Lewy body diseases."

For the study, the researchers developed and tested peptides known as TLR2-interacting domain of MYd88 (TIDM) and NEMO-binding domain (NBD) on mouse models of Parkinson's disease. In doing so, they found that the drugs could reduce inflammation in the brain, halt the spread of alpha-synuclein and protect dopaminergic neurons. The drugs also improved the gait, balance, and other motor functions of the mice. 

The researchers conclude that their nasal drugs are able to reduce the spread of alpha-synuclein and that they demonstrate the pathways by which the proteins spread and are linked to Parkinson's disease. 

The researchers now look forward to replicating their study on patients. If the results translate over to humans too, they say that that the treatment would be a 'remarkable advance in the treatment of devastating neurological disorders'. 

 

Sources: Nature CommunicationsNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 10, 2021
Immunology
A Tapeworm Drug as a COVID Antiviral?
AUG 10, 2021
A Tapeworm Drug as a COVID Antiviral?
A study by researchers at the Scripps Research Institute looking into potential COVID-19 medications has revealed a surp ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
OCT 04, 2021
Drug Discovery & Development
Tylenol During Pregnancy Linked to Developmental Disorders
OCT 04, 2021
Tylenol During Pregnancy Linked to Developmental Disorders
The use of common painkiller acetaminophen (APAP), also known as paracetamol and often sold as Tylenol, during pregnancy ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
Loading Comments...